Silver Lining In Sight? Stunted Growth In Indian Pharma Market Is A “Pseudo Slowdown”
This article was originally published in PharmAsia News
A free fall in growth rates for the Indian pharmaceutical market has sparked concerns in the industry. But after a few quarters, analysts say they have decoded the anomaly and brighter days may be ahead.